Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Tolley, Elizabeth E.; Zangeneh, Sahar Z.; Chau, Gordon; Eron, Joe; Grinsztejn, Beatriz; Humphries, Hilton; Liu, Albert; Siegel, Marc; Bertha, Maseko; Panchia, Ravindre; Li, Sue; Cottle, Leslie; Rinehart, Alex; Margolis, David; Jennings, Andrea; McCauley, Marybeth; Landovitz, Raphael J..
Artículo en Inglés | ARCA | ID: arc-40294

Documentos relacionados

  1. Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077.
  2. [Tear Film Osmolarity in Normal Individuals: Comparison of Two Osmometers].
  3. [Use of Health Care by Homeless Individuals: Results of the Hamburg Survey of Homeless Individuals].
  4. A Retrospective Analysis of Preclinical and Clinical Pharmacokinetics from Administration of Long-Acting Aqueous Suspensions.
  5. [The Safety of Using Long-acting Injections : From an Opposing Position-Is It Better to Administer Long-acting Injections?].
  6. An Injection of Innovation: How Drug Delivery Systems are Changing.
  7. Acceptance Rate and Reasons for Rejection of Long Acting Injectable Antiretrovirals.
  8. A Novel Method to Optimize Drug Delivery for Parenteral Products Involving New Therapies and Unmet Needs.
  9. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial.
  10. [Osteometry of the femora in Turkish individuals: a morphometric study in 114 cadaveric femora as an anatomic basis of femoral component design].